Unknown

Dataset Information

0

Ultrasmall metal alloy nanozymes mimicking neutrophil enzymatic cascades for tumor catalytic therapy.


ABSTRACT: Developing strategies that emulate the killing mechanism of neutrophils, which involves the enzymatic cascade of superoxide dismutase (SOD) and myeloperoxidase (MPO), shows potential as a viable approach for cancer therapy. Nonetheless, utilizing natural enzymes as therapeutics is hindered by various challenges. While nanozymes have emerged for cancer treatment, developing SOD-MPO cascade in one nanozyme remains a challenge. Here, we develop nanozymes possessing both SOD- and MPO-like activities through alloying Au and Pd, which exhibits the highest cascade activity when the ratio of Au and Pd is 1:3, attributing to the high d-band center and adsorption energy for superoxide anions, as determined through theoretical calculations. The Au1Pd3 alloy nanozymes exhibit excellent tumor therapeutic performance and safety in female tumor-bearing mice, with safety attributed to their tumor-specific killing ability and renal clearance ability caused by ultrasmall size. Together, this work develops ultrasmall AuPd alloy nanozymes that mimic neutrophil enzymatic cascades for catalytic treatment of tumors.

SUBMITTER: Meng X 

PROVIDER: S-EPMC10884023 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Ultrasmall metal alloy nanozymes mimicking neutrophil enzymatic cascades for tumor catalytic therapy.

Meng Xiangqin X   Fan Huizhen H   Chen Lei L   He Jiuyang J   Hong Chaoyi C   Xie Jiaying J   Hou Yinyin Y   Wang Kaidi K   Gao Xingfa X   Gao Lizeng L   Yan Xiyun X   Fan Kelong K  

Nature communications 20240222 1


Developing strategies that emulate the killing mechanism of neutrophils, which involves the enzymatic cascade of superoxide dismutase (SOD) and myeloperoxidase (MPO), shows potential as a viable approach for cancer therapy. Nonetheless, utilizing natural enzymes as therapeutics is hindered by various challenges. While nanozymes have emerged for cancer treatment, developing SOD-MPO cascade in one nanozyme remains a challenge. Here, we develop nanozymes possessing both SOD- and MPO-like activities  ...[more]

Similar Datasets

| S-EPMC8184917 | biostudies-literature
| S-EPMC9814734 | biostudies-literature
| S-EPMC8397296 | biostudies-literature
| S-EPMC8897311 | biostudies-literature
| S-EPMC7419420 | biostudies-literature
| S-EPMC5285510 | biostudies-literature
| S-EPMC8899206 | biostudies-literature
| S-EPMC7318245 | biostudies-literature
| S-EPMC10460896 | biostudies-literature
| S-EPMC10082843 | biostudies-literature